Innovative science meets commercial expertise

AgraFilms is poised to bring amoebic biocontrol into the mainstream.

 

Our story

 

AmebaGone was founded in 2010 with the goal of commercializing a revolutionary approach to biocontrol: harnessing the natural predatory behavior of amoebae to combat disease-causing microbes. Our technology has wide applications in the medical setting, including sterilization, biohazard control, and the treatment of wounds and diseases. AgraFilms, founded in 2018, deploys amoebic biocontrol in crops and food storage to improve efficiency and safety. 

 

Our core technology was developed by founders Marcin Filutowicz and Katarzyna Borys at the University of Wisconsin-Madison.

  

Together with AmebaGone, AgraFilms has the potential to positively impact human health, water safety, agricultural productivity, and quality of life worldwide.

Our advantage

agone-17.png

3 issued patents

"Therapeutic Amoeba and Uses Thereof" (US8551471B2) EU version filed (EP2575833B1)

"Dictyostelid Amoeba and Biocontrol Uses Thereof" (US 163/014,473)

agone-16.png

3 collections of Dicty amoebae exclusively licensed to AgraFilms

With exclusive licenses for two

agone-15.png

3,000+ unique isolates

From all over the world and some habitats that no longer exist

AmebaGone and AgraFilms have 5 granted patents covering therapeutic use of amoeba in the United States, Germany, France and the United Kingdom as well as 5 provisional patents covering amoeba use for anti-biofilm agents, potato soft rot treatment, and therapeutics in the United States.